Merck Historical Financial Ratios

MRK
 Stock
  

USD 90.59  0.01  0.011%   

Merck is lately reporting on over 76 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PPandE Turnover of 2.64 will help investors to properly organize and evaluate Merck Company financial condition quickly. Financial Statement Analysis is infinitely more than just reviewing and investigating Merck Company recent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merck Company is a good buy for the upcoming year.
Additionally, see Stocks Correlation.
  

About Merck Financial Ratios Analysis

Merck CompanyFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Merck investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Merck financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Merck history.

Merck Financial Ratios Chart

Merck Company financial ratios usually calculated using numerical values taken directly from Merck financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Merck. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
Merck Inventory Turnover is decreasing as compared to previous years. The last year's value of Inventory Turnover was reported at 2.22. The current Accounts Payable Turnover is estimated to increase to 14.94, while Operating Margin is projected to decrease to 20.62.

Return on Average Assets

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].

Return on Average Equity

Return on equity measures a corporation's profitability by calculating the amount of Net Income Common Stock returned as a percentage of [EquityAvg].

Return on Sales

Return on Sales is a ratio to evaluate a company's operational efficiency; calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont ROE analysis.
Most ratios from Merck fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Additionally, see Stocks Correlation.Merck Inventory Turnover is decreasing as compared to previous years. The last year's value of Inventory Turnover was reported at 2.22. The current Accounts Payable Turnover is estimated to increase to 14.94, while Operating Margin is projected to decrease to 20.62.
 2019 2020 2021 2022 (projected)
Long Term Debt to Equity0.881.00.80.67
Interest Coverage18.7410.2416.2814.72

Merck fundamentals Correlations

0.3-0.330.59-0.37-0.14-0.32-0.450.780.340.560.220.21-0.1-0.310.09-0.37-0.410.27-0.370.21-0.010.040.040.160.29
0.3-0.340.260.23-0.51-0.9-0.790.60.730.70.510.670.17-0.910.43-0.9-0.930.97-0.780.85-0.120.390.390.330.84
-0.33-0.340.07-0.03-0.020.220.28-0.590.1-0.55-0.72-0.1-0.480.06-0.20.120.2-0.290.32-0.46-0.04-0.44-0.44-0.13-0.24
0.590.260.07-0.140.22-0.27-0.420.160.310.03-0.150.31-0.68-0.23-0.37-0.53-0.280.27-0.57-0.18-0.05-0.39-0.390.50.51
-0.370.23-0.03-0.14-0.01-0.050.27-0.09-0.010.260.290.48-0.24-0.180.3-0.31-0.190.37-0.230.210.10.280.28-0.150.14
-0.14-0.51-0.020.22-0.010.40.28-0.55-0.41-0.58-0.38-0.61-0.340.61-0.650.390.51-0.50.14-0.60.02-0.47-0.470.33-0.13
-0.32-0.90.22-0.27-0.050.40.81-0.54-0.88-0.58-0.38-0.48-0.210.9-0.390.780.9-0.830.72-0.79-0.01-0.42-0.42-0.24-0.7
-0.45-0.790.28-0.420.270.280.81-0.52-0.61-0.41-0.26-0.24-0.240.73-0.020.650.75-0.670.75-0.63-0.04-0.24-0.24-0.44-0.72
0.780.6-0.590.16-0.09-0.55-0.54-0.520.40.910.620.460.33-0.550.5-0.47-0.640.56-0.450.690.110.550.55-0.090.32
0.340.730.10.31-0.01-0.41-0.88-0.610.40.450.230.410.0-0.820.43-0.72-0.790.68-0.510.59-0.260.140.150.290.64
0.560.7-0.550.030.26-0.58-0.58-0.410.910.450.660.610.27-0.630.72-0.6-0.720.71-0.530.820.090.650.66-0.130.39
0.220.51-0.72-0.150.29-0.38-0.38-0.260.620.230.660.360.46-0.340.43-0.3-0.370.47-0.350.57-0.130.50.50.070.32
0.210.67-0.10.310.48-0.61-0.48-0.240.460.410.610.36-0.28-0.670.52-0.78-0.630.77-0.550.470.040.320.32-0.120.44
-0.10.17-0.48-0.68-0.24-0.34-0.21-0.240.330.00.270.46-0.28-0.10.240.27-0.090.030.190.520.060.540.54-0.19-0.12
-0.31-0.910.06-0.23-0.180.610.90.73-0.55-0.82-0.63-0.34-0.67-0.1-0.490.870.97-0.910.68-0.780.01-0.39-0.39-0.11-0.67
0.090.43-0.2-0.370.3-0.65-0.39-0.020.50.430.720.430.520.24-0.49-0.38-0.510.51-0.210.680.020.630.64-0.380.09
-0.37-0.90.12-0.53-0.310.390.780.65-0.47-0.72-0.6-0.3-0.780.270.87-0.380.89-0.950.83-0.620.16-0.15-0.15-0.37-0.85
-0.41-0.930.2-0.28-0.190.510.90.75-0.64-0.79-0.72-0.37-0.63-0.090.97-0.510.89-0.940.74-0.830.02-0.4-0.4-0.18-0.72
0.270.97-0.290.270.37-0.5-0.83-0.670.560.680.710.470.770.03-0.910.51-0.95-0.94-0.780.81-0.120.360.360.270.81
-0.37-0.780.32-0.57-0.230.140.720.75-0.45-0.51-0.53-0.35-0.550.190.68-0.210.830.74-0.78-0.56-0.2-0.33-0.33-0.35-0.74
0.210.85-0.46-0.180.21-0.6-0.79-0.630.690.590.820.570.470.52-0.780.68-0.62-0.830.81-0.560.050.70.70.010.53
-0.01-0.12-0.04-0.050.10.02-0.01-0.040.11-0.260.09-0.130.040.060.010.020.160.02-0.12-0.20.050.640.64-0.68-0.46
0.040.39-0.44-0.390.28-0.47-0.42-0.240.550.140.650.50.320.54-0.390.63-0.15-0.40.36-0.330.70.641.0-0.59-0.11
0.040.39-0.44-0.390.28-0.47-0.42-0.240.550.150.660.50.320.54-0.390.64-0.15-0.40.36-0.330.70.641.0-0.58-0.11
0.160.33-0.130.5-0.150.33-0.24-0.44-0.090.29-0.130.07-0.12-0.19-0.11-0.38-0.37-0.180.27-0.350.01-0.68-0.59-0.580.77
0.290.84-0.240.510.14-0.13-0.7-0.720.320.640.390.320.44-0.12-0.670.09-0.85-0.720.81-0.740.53-0.46-0.11-0.110.77
Click cells to compare fundamentals

Merck Account Relationship Matchups

Merck fundamentals Accounts

201720182019202020212022 (projected)
Interest Coverage17.719.3418.7410.2416.2814.72
Long Term Debt to Equity0.620.740.881.00.80.67
Calculated Tax Rate63.3328.8214.7219.4410.9611.25
PPandE Turnover3.283.293.312.92.612.64
Receivables Turnover5.885.786.076.766.545.7
Accounts Payable Turnover13.5813.1813.2811.4910.5814.94
Accrued Expenses Turnover30.4430.4530.7729.3528.333.66
Operating Margin16.2819.6224.7716.4725.7420.62
Cash and Equivalents Turnover6.376.025.315.46.035.2
Return on Investment10.5615.0122.314.4619.5321.07
Cash Flow Per Share2.394.215.294.055.194.38
Total Assets Per Share32.5931.8733.2436.241.8236.8
Quick Ratio0.830.720.780.580.730.98
Net Current Assets as percentage of Total Assets7.04.446.240.486.059.19
Book Value per Share12.610.2710.1810.0115.1214.01
Current Ratio1.331.171.241.021.271.32
Debt to Equity Ratio1.552.092.252.611.771.81
Dividends per Basic Common Share1.891.992.262.482.642.53
Earnings per Basic Share0.882.343.842.795.164.17
Earnings per Diluted Share0.872.323.812.785.144.15
Earnings per Basic Share USD0.882.343.842.795.164.17
Enterprise Value over EBIT39.027.025.022.014.020.79
Enterprise Value over EBITDA15.4316.1916.9719.211.8114.01
Free Cash Flow per Share1.683.23.962.33.833.81
Profit Margin0.060.150.250.170.270.24
Payout Ratio2.150.850.590.890.510.68
Price to Book Value4.477.448.948.185.075.41
Price to Earnings Ratio63.9432.6523.6929.3214.8515.24
Price to Sales Ratio3.824.75.924.993.984.37
Return on Average Assets0.040.0260.0730.0790.140.11
Return on Average Equity0.0630.20.370.260.390.31
Return on Sales0.160.210.290.20.30.28
Sales per Share14.7316.2715.3716.4119.2819.19

Be your own money manager

Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Merck Company using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.54
Market Capitalization
229.5 B
Quarterly Revenue Growth YOY
0.28
Return On Assets
0.13
Return On Equity
0.43
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.